Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Slouching Toward Phase 3: Progress Report On New Cholesterol Drugs At The AHA
Forbes
Mon, 11/25/13 - 09:12 am
Tags:
cholesterol, PCSK9 inhibitors, evolocumab, Amgen
3 New Cholesterol Treatments Worth Watching
Motley Fool
Sun, 11/24/13 - 12:46 pm
Tags:
Sanofi, Regeneron, Amgen, alirocumab, AMG 145, RN-316, Pfizer
U.S. FDA Approves NEXAVAR (sorafenib) for the Treatment of Patients with Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory to Radioactive Iodine Treatment
Yahoo/PR NewsWire
Sat, 11/23/13 - 12:06 pm
Tags:
Nexavar, Bayer, ONYX Pharmaceuticals, Amgen, thyroid cancer, refractory differential thyroid cancer
Data on Amgen's Pipeline Candidates
Yahoo/Zacks.com
Thu, 11/21/13 - 11:05 am
Tags:
Amgen, evolocumab, PCSK9 inhibitors, cholesterol, Talimogene Laherparepvec
Amgen cholesterol drug appears safe, cut LDL 52 pct at 1 year-study
Yahoo/Reuters
Wed, 11/20/13 - 08:31 am
Tags:
Amgen, cholesterol, asevolocumab, PCSK9 inhibitors
Celgene Vs. Rivals In Psoriatic Arthritis Drug Race
Seeking Alpha
Wed, 11/20/13 - 08:29 am
Tags:
psoriatic arthritis, Celgene, AbbVie, Amgen, JNJ, Merck, Humira, apremilast, Enbrel, Stelara, Simponi, Remicade
Keep an Eye on BioMarin, Amgen, Merck, and AstraZeneca Today
Motley Fool
Tue, 11/19/13 - 12:24 pm
Tags:
Biomarin, Amgen, Merck, AstraZeneca
Amgen presents survival data from Phase 3 study of talimogene laherparepvec
Yahoo/Fly on the Wall
Mon, 11/18/13 - 04:39 pm
Tags:
Amgen, Talimogene Laherparepvec, melanoma
Has Myeloma Met Its Match in Amgen's Kyprolis?
Motley Fool
Mon, 11/18/13 - 11:07 am
Tags:
Multiple Myeloma, Amgen, Kyprolis, Celgene
A Shifting Paradigm in Heart Disease Could Affect These Drugmakers
Motley Fool
Mon, 11/18/13 - 10:01 am
Tags:
heart disease, Amgen, statins, Regeneron, Pfizer, Sanofi, PCSK9 inhibitors
FDA says new cholesterol drugs may not need outcome studies
Yahoo/Reuters
Fri, 11/15/13 - 08:37 am
Tags:
FDA, cholesterol, PCSK9 inhibitors, statins, Pfizer, Amgen, Sanofi, Regeneron
Watch The R&D Chiefs Of Pfizer, Merck, And Amgen Discuss The Drug Industry's Challenges
Forbes
Thu, 11/14/13 - 10:31 am
Tags:
R&D, Pfizer, Amgen, Merck
U.S. heart guidelines may threaten hot new cholesterol drugs
Yahoo/Reuters
Wed, 11/13/13 - 12:47 pm
Tags:
cholesterol, statins, PCSK9 inhibitors, Sanofi, Regeneron, Pfizer, Amgen
Small Esperion Vs Pharma Giants In The Cholesterol Race
Seeking Alpha
Mon, 11/11/13 - 10:35 am
Tags:
Esperion Therapeutics, ETC-1002, Sanofi, Regeneron, Amgen, Pfizer, Roche
Roche Pacing the Field in the Biotech Race
TheStreet.com
Wed, 11/6/13 - 08:20 am
Tags:
Roche, Amgen, Gilead, Sanofi, Celgene
Meet the Tiny Biotech Challenging Amgen and General Electric
Motley Fool
Tue, 11/5/13 - 08:08 am
Tags:
Amgen, Repligen, General Electric
3 Blockbuster Drugs Losing Patent Protection in 2013's Final Months
Motley Fool
Fri, 11/1/13 - 08:38 am
Tags:
patents, Amgen, Neupogen, Merck KGaA, Rebif, Cymbalta, Eli Lilly
The Wisdom -- And Risk -- Of Pfizer's New Cholesterol Drug Development Plan
Forbes
Fri, 11/1/13 - 08:28 am
Tags:
Pfizer, PCSK9 inhibitors, RN-316, Sanofi, Regeneron, REGN727, AMG145, Amgen
This Biotech Trifecta Could Revolutionize Cancer
Motley Fool
Sun, 10/27/13 - 12:53 pm
Tags:
Intrexon, Ziopharm, Amgen, Osiris Therapeutics
Q3 Earnings Roundup for Pharmaceutical Stocks
InvestorPlace
Fri, 10/25/13 - 11:37 am
Tags:
earnings, Amgen, Eli Lilly, Bristol-Myers Squibb

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.